PSMA-Targeted Imaging and Therapy
Developing PSMA-targeted imaging and therapeutic agents to improve detection, staging, treatment planning, and management of prostate cancer.
Molecular Imaging Agent Development
Designing and translating new molecular imaging agents that reveal disease processes at the cellular and molecular level.
Theranostics and Next-Generation Radiopharmaceuticals
Advancing next-generation radiopharmaceuticals that combine targeted imaging and therapy to support more personalized cancer care.
CNS Disease, Neuroinflammation, and Brain Tumor Imaging
Creating molecular imaging approaches to study central nervous system disorders, neuroinflammation, and brain tumors.
